MedPath

A Comparative Study on Type 2 Diabetes Mellitus

Phase 2
Conditions
Health Condition 1: null- with controlled systemic disorders
Registration Number
CTRI/2018/06/014635
Lead Sponsor
Shweta Ramesh Aswar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient having fasting plasma glucose level 126mg/dl to 200mg/dl and post prandial plasma glucose level 200mg/dl to250mg/dl.

2.HbA1c is 6.5% up to 8.5%. (In standardised assay, the HbA1c approximates the estimated average glucose value according to ADAG formula (A1c Derivated

Average Glucose Level) that is 140mg/dl to197mg/dl[29]

3.Patients fulfilling criteria of diagnosis and having clinical features of Sthula

Madhumeha (Diabetes Mellitus)

4.Patients having BMI more than 23Kg/m2 up to 30Kg/m2 will be selected.

5.Those are willing to participate in trial and ready to give written consent.

6.Patients with controlled Hypertension.

Exclusion Criteria

1.Patients who already taken anti Diabetic drugs.

2.Patients having Insulin Dependent Diabetes Mellitus and Juvenile Diabetes and various other types of Diabetes except Type II DM

3.Patients having complications such as vasculopathy, nephropathy, retinopathy and neuropathy.

4.Patients having other systemic complications like hepatic, renal and cardiac problems.

5.Pregnant and lactating females not included in this study.

6.Patients who are currently participating in any other clinical trials since last 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath